本文翻译正在准备中。在此之前，我们暂时显示英文原文。
企业公告 · 2026/11/131 分钟阅读
Leqembi® Pen subcutaneous treatment launched in Japan
本地自动翻译 · 来源原始语言
摘要
STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…
来源原始语言: PR Newswire UK — News Releases打开原始公告 →